title: In brief: Two Drugs for soft-tissue sarcoma.
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects / Q000627:therapeutic use*; D004149:Dioxoles / Q000009:adverse effects / Q000627:therapeutic use*; D018450:Disease Progression; D005663:Furans / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007659:Ketones / Q000009:adverse effects / Q000627:therapeutic use*; D012509:Sarcoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D012983:Soft Tissue Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D044005:Tetrahydroisoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D000077606:Trabectedin; D016896:Treatment Outcome; D050257:Tubulin Modulators / Q000009:adverse effects / Q000627:therapeutic use*; D000095662:Polyether Polyketides
chemical_list: D018906:Antineoplastic Agents, Alkylating; D004149:Dioxoles; D005663:Furans; D007659:Ketones; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin; D050257:Tubulin Modulators; C490954:eribulin; D000095662:Polyether Polyketides